Search research articles
Contact Us
Filters
Showing results (111-120 of 147) with videos related to
Page
of 15
Sort By:
European Archives of Psychiatry and Clinical Neuroscience
|
March 25, 2017
Is prepulse modification altered by continuous theta burst stimulation? DAT1 genotype and motor threshold interact on prepulse modification following brain stimulation
S Notzon, N Vennewald, A Gajewska, et al.
Journal of Advanced Nursing
|
November 1, 2001
Mental disturbances and perceived complexity of nursing care in medical inpatients: results from a European study
P D Jonge, M M Zomerdijk, F J Huyse, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
November 13, 2016
Brain-derived Neurotrophic Factor (BDNF) and gray matter volume in bipolar disorder
S Poletti, V Aggio, T A Hoogenboezem, et al.
Molecular Psychiatry
|
February 24, 2006
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine
N Müller, M J Schwarz, S Dehning, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
June 13, 2008
The functional anatomy of semantic retrieval is influenced by gender, menstrual cycle, and sex hormones
C Konrad, A Engelien, S Schöning, et al.
Psychological Medicine
|
April 25, 2013
Altered top-down and bottom-up processing of fear conditioning in panic disorder with agoraphobia
U Lueken, B Straube, I Reinhardt, et al.
Molecular Psychiatry
|
July 9, 2004
Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF
M Rothermundt, P Falkai, G Ponath, et al.
Psychosomatics
|
May 15, 2001
Risk factors for complex care needs in general medical inpatients: results from a European study
P de Jonge, F J Huyse, T Herzog, et al.
Molecular Psychiatry
|
March 29, 2017
Prefrontal gray matter volume mediates genetic risks for obesity
N Opel, R Redlich, C Kaehler, et al.
Pharmacopsychiatry
|
March 30, 2012
Naturalistic pharmacotherapy of acute episodes of schizophrenic disorders in comparison to treatment guidelines
M Stein, D E Dietrich, M W Agelink, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 147) with videos related to
Sort By:
Page
of 15
European Archives of Psychiatry and Clinical Neuroscience
|
March 25, 2017
Is prepulse modification altered by continuous theta burst stimulation? DAT1 genotype and motor threshold interact on prepulse modification following brain stimulation
S Notzon, N Vennewald, A Gajewska, et al.
Journal of Advanced Nursing
|
November 1, 2001
Mental disturbances and perceived complexity of nursing care in medical inpatients: results from a European study
P D Jonge, M M Zomerdijk, F J Huyse, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
November 13, 2016
Brain-derived Neurotrophic Factor (BDNF) and gray matter volume in bipolar disorder
S Poletti, V Aggio, T A Hoogenboezem, et al.
Molecular Psychiatry
|
February 24, 2006
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine
N Müller, M J Schwarz, S Dehning, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
June 13, 2008
The functional anatomy of semantic retrieval is influenced by gender, menstrual cycle, and sex hormones
C Konrad, A Engelien, S Schöning, et al.
Psychological Medicine
|
April 25, 2013
Altered top-down and bottom-up processing of fear conditioning in panic disorder with agoraphobia
U Lueken, B Straube, I Reinhardt, et al.
Molecular Psychiatry
|
July 9, 2004
Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF
M Rothermundt, P Falkai, G Ponath, et al.
Psychosomatics
|
May 15, 2001
Risk factors for complex care needs in general medical inpatients: results from a European study
P de Jonge, F J Huyse, T Herzog, et al.
Molecular Psychiatry
|
March 29, 2017
Prefrontal gray matter volume mediates genetic risks for obesity
N Opel, R Redlich, C Kaehler, et al.
Pharmacopsychiatry
|
March 30, 2012
Naturalistic pharmacotherapy of acute episodes of schizophrenic disorders in comparison to treatment guidelines
M Stein, D E Dietrich, M W Agelink, et al.
Page
of 15